01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- −$447.0M
1 older move runs past ±150% (largest −239.0%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is BridgeBio Pharma's current free cash flow?
BridgeBio Pharma (BBIO) annual free cash flow for 2025 was $-447.0M, a 14.31% increase from 2024. BridgeBio Pharma free cash flow for the quarter ending September 30, 2026 was $-44.5M.
What was BridgeBio Pharma's free cash flow in 2024?
BridgeBio Pharma annual free cash flow for 2024 was $-521.7M, a 1.39% increase from 2023.
What was BridgeBio Pharma's free cash flow in 2023?
BridgeBio Pharma annual free cash flow for 2023 was $-529.0M, a 24.68% decline from 2022.
- Company
- BridgeBio Pharma
- Ticker
- BBIO
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations